Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 November 2022 | Story Edzani Nephalela and Dr Nomalungelo Ngubane | Photo iStock
Language
The UFS and UKZN have formalised an agreement on a Language Collaboration Memorandum of Understanding (MOU) to advance the development of the Sesotho and IsiZulu as academic languages.

The University of the Free State (UFS) has forged an exciting new partnership with the University of KwaZulu-Natal (UKZN) to promote the two provinces’ most widely spoken languages, Sesotho and IsiZulu.  

This historic collaboration will see these institutions employing their skills, expertise, and resources to advance the development of the Sesotho and IsiZulu as academic languages through the development of terminology for various disciplines and research collaborations among other activities. 

The UFS formalised the agreement by signing a Language Collaboration Memorandum of Understanding (MOU) with UKZN. The MOU process, facilitated by Dr Nomalungelo Ngubane, Director of the UFS Academy for Multilingualism, and Nikile Ntsababa, UFS Registrar, was sealed by Dr Engela Van Staden, UFS Vice-Rector: Academic. 

The objectives of the collaboration are to: 

• allow the UFS open access to all the UKZN isiZulu materials and UKZN open access to all UFS Sesotho language terminology, corpus materials, terminology banks, and applications for various disciplines; 
• develop the Sesotho terminology for various disciplines;
• assist in identifying and closing any gaps in the UFS’s development of isiZulu terminology and in the UKZN’s development of isiZulu, and further develop the relevant language terminology of various disciplines in order to fill any existing gaps;
• share expertise through hosting webinars, seminars, colloquia, and workshops on Sesotho and isiZulu terminology development;
• explore research opportunities regarding the development of Sesotho and isiZulu terminology for various disciplines; and 
• share expertise and resources in all human language technology development initiatives.

“The UKZN has championed the intellectualisation of IsiZulu over the years. We do not want to reinvent the wheel,” Dr Ngubane said. “Our focus now is on the acceleration of the development of Sesotho. Our vision and mission is to be the hub for the advancement of Sesotho at regional, national, and international levels. Collaboration with UKZN is instrumental in achieving this mandate.”

The Academy for Multilingualism said it considers this collaboration historic and groundbreaking because resources will now be invested in the development of Sesotho.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept